...
首页> 外文期刊>Oncology letters >Frequent aberrant p53 and Fhit expression in endoscopically resected superficial hypopharyngeal cancer and esophageal cancer
【24h】

Frequent aberrant p53 and Fhit expression in endoscopically resected superficial hypopharyngeal cancer and esophageal cancer

机译:内镜切除肤浅的肤浅癌症和食管癌中常见的异常P53和FHIT表达

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In the last decade, the incidence rate of detection rate of superficial head, neck and esophageal squamous cell carcinomas has increased with the development of endoscopic imaging techniques. These cancers are thought to arise independently subsequent to tissue exposure to a common carcinogen e.g. alcohol or tobacco. This phenomenon has been termed field cancerization. To determine the molecular background of the development of hypopharyngeal squamous cell carcinomas (HPSCCs) and double esophageal squamous cell carcinomas (DESCCs), the present study immunohistochemically assessed tumor-related protein expression [p53, Fhit (fragile histidine triad), E-cadherin and activation-induced cytidine deaminase (AID)], and subsequently determined the correlation between protein expression and clinicopathological data. Tumor specimens of 9 HPSCCs and 9 DESCCs were endoscopically obtained from 8 patients with HPSCC. The 9 DESCCs, including 5 synchronous and 4 metachronous lesions, were all obtained from four patients with HPSCC. The overexpression of p53 and loss of Fhit expression was immunohistochemically detected in 8 (88.9%) and 8 (88.9%) of the 9 HPSCCs and in 8 (88.9%) and 8 (88.9%) of the 9 DESCCs, respectively, which demonstrated the high frequency of such expression. Additionally, 7 out of 9 HPSCCs, and 7 out of 9 DESCCs demonstrated aberrant expression of p53 and Fhit. The rate of aberrant AID and E-cadherin expression was 67 and 44% in HPSCCs and 44 and 44% in DESCC, respectively. These results suggested that aberrant p53 and Fhit expression was involved in the development of HPSCC and their. DESCC, and that their expression may be used for the prediction of DESCC development in patients with HPSCC, thereby acting as a biomarker of field cancerization.
机译:在过去的十年中,随着内窥镜成像技术的发展,浅表头部,颈部和食管鳞状细胞癌的检出率的发病率增加。这些癌症被认为在组织暴露于常见的癌症之后独立地出现。酒精或烟草。这种现象已被称为现场癌症。为了确定白糖鳞状细胞癌(HPSCC)和双食管鳞状细胞癌(DESCC)的发育的分子背景,本研究免疫组化评估肿瘤相关蛋白表达[P53,FHIT(脆弱的组氨酸三联),E-Cadherin和活化诱导的胞嘧啶脱氨酶(AID)],随后确定蛋白质表达和临床病理数据之间的相关性。 9个HPSCC和9个DESCC的肿瘤标本从8例HPSCC患​​者内窥镜上进行内窥镜。 9个DESCC,包括5个同步和4个同叉病变,全部从4例HPSCC中获得。 P53的过表达分别在8(88.9%)和8(88.9%)和8(88.9%)和8(88.9%)中的8(88.9%)和8(88.9%)中显示出来的8(88.9%)的过表达。这种表达的高频。另外,7个HPSCC中的7个,9个中的7个中可以表达P53和FHIT的异常表达。异常助剂和e-cadherin表达的速率分别在HPSCCs和44%和44%的下移中的速率为67%和44%。这些结果表明,异常的P53和FHIT表达涉及HPSCC及其的发展。 DESCC,并且它们的表达可用于预测HPSCC患​​者的DESCC发育,从而作用为野外癌症的生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号